FGF21 levels correlate with various cardiometabolic conditions, and higher FGF21 expression is associated with cardiovascular risk factors such as chronic inflammation, obesity, hypertriglyceridemia, and elevated liver enzymes [91,92]. The gene discussed is FGF21; the disease is hypertriglyceridemia.